Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Otolaryngology
Volume 2015, Article ID 631098, 4 pages
http://dx.doi.org/10.1155/2015/631098
Case Report

A Case of Oropharyngeal Bullous Pemphigoid Presenting with Haemoptysis

1Department of Dermatology, Royal Berkshire Hospital, London Road, Reading, Berkshire RG1 5AN, UK
2Department of Ear, Nose and Throat Surgery, Royal Berkshire Hospital, Reading RG1 5AN, UK
3University College London Ear Institute, 332 Grays Inn Road, London WC1X 8EE, UK

Received 12 October 2014; Revised 17 November 2014; Accepted 11 December 2014

Academic Editor: Yorihisa Orita

Copyright © 2015 C. M. Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Shirakata, S. Shiraishi, K. Sayama, and Y. Miki, “Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus,” The Journal of Dermatology, vol. 17, no. 11, pp. 661–666, 1990. View at Google Scholar · View at Scopus
  2. E. Cozzani, M. Drosera, A. Parodi, M. Carrozzo, S. Gandolfo, and A. Rebora, “Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid,” Acta Dermato-Venereologica, vol. 84, no. 5, pp. 381–384, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. R. S. Labib, G. J. Anhalt, H. P. Patel, D. F. Mutasim, and L. A. Diaz, “Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting,” The Journal of Immunology, vol. 136, no. 4, pp. 1231–1235, 1986. View at Google Scholar · View at Scopus
  4. J. E. Miller and M. J. Rico, “IgG antibodies from patients with bullous pemphigoid bind to fusion proteins encoded by BPAg1 cDNA,” Journal of Investigative Dermatology, vol. 114, pp. 998–1004, 2000. View at Publisher · View at Google Scholar · View at PubMed
  5. S. C. Hofmann, S. Thoma-Uszynski, T. Hunziker et al., “Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain,” Journal of Investigative Dermatology, vol. 119, no. 5, pp. 1065–1073, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. T. Burns, S. Breathnach, N. Cox, and C. Griffith, “Subepidermal immunobullous diseases,” in Rook's Textbook of Dermatology, chapter 40.32, 8th edition, 2010. View at Google Scholar
  7. A. Anstey, V. Venning, F. Wojnarowska, B. Bhogal, and M. M. Black, “Determination of the optimum site for diagnostic biopsy for direct immunofluorescence in bullous pemphigoid,” Clinical & Experimental Dermatology, vol. 15, no. 6, pp. 438–441, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Rzany, K. Partscht, M. Jung et al., “Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age,” Archives of Dermatology, vol. 138, no. 7, pp. 903–908, 2002. View at Google Scholar · View at Scopus
  9. S. Murono, Y. Nakanishi, M. Fujimoto, and T. Yoshizaki, “Hypopharyngeal presentation of cicatricial pemphigoid: videofluorographic and direct laryngoscopic findings,” Journal of Laryngology and Otology, vol. 127, no. 4, pp. 429–431, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. K. Saravanan, S. T. Baer, A. Meredith, A. Dyson, and J. Von Der Werth, “Benign mucous membrane pemphigoid of the upper aero-digestive tract: rare paraneoplastic syndrome presentation in renal cell carcinoma,” Journal of Laryngology and Otology, vol. 120, no. 3, pp. 237–239, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. O. J. H. Whiteside, P. M. Devesa, I. Ali, and J. W. R. Capper, “Mucous membrane pemphigoid: nasal and laryngeal manifestations,” The Journal of Laryngology & Otology, vol. 117, no. 11, pp. 885–888, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. N. Maharshak, M. Sagi, E. Santos, E. Sprecher, and I. Goldberg, “Oesophageal involvement in bullous pemphigoid,” Clinical and Experimental Dermatology, vol. 38, no. 3, pp. 274–275, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. V. A. Venning, K. Taghipour, M. F. Mohd Mustapa, A. S. Highet, and G. Kirtschig, “British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012,” British Journal of Dermatology, vol. 167, no. 6, pp. 1200–1214, 2012. View at Publisher · View at Google Scholar · View at PubMed
  14. S. Beissert, T. Werfel, U. Frieling et al., “A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid,” Archives of Dermatology, vol. 143, no. 12, pp. 1536–1542, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. P. Joly, J. Benichou, C. Lok et al., “Prediction of survival for patients with BP: a prospective study,” Archives of Dermatology, vol. 141, pp. 691–698, 2005. View at Google Scholar